EUCTR2004-001988-21-IT进行中（未招募）不适用
A phase II trial randomised, parallel group, double-blind, active controlled study to investigate the efficacy and safety of two different dose regimens of orally administered dabigatran etexilate capsuled [150 or 220 mg once daily strating wiht half dose (i.e. 75 or 110 mg)on the day of surgery] compared to subcutaneous enoxaparin 40 mg once daily for 28-35 days, in prevention of venous thromboembolism in patients with primary elective total hip replacement surgery.
BOEHRINGER ING.0 个研究点开始时间: 2005年3月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A study to test whether different doses of BI 456906 are effective in treating adults with type 2 diabetesEUCTR2019-002390-60-HUBoehringer Ingelheim RCV GmbH & Co KG669
进行中（未招募）
1 期
A study to test whether different doses of BI 456906 are effective in treating adults with type 2 diabetesEUCTR2019-002390-60-ESBoehringer Ingelheim España, S.A.410
进行中（未招募）
1 期
A study to test whether different doses of BI 456906 are effective in treating adults with type 2 diabetestype 2 diabetes mellitusMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-002390-60-DEBoehringer Ingelheim Pharma GmbH & Co. KG410
进行中（未招募）
1 期
A study to test whether different doses of BI 456906 are effective in treating adults with type 2 diabetesEUCTR2019-002390-60-CZBoehringer Ingelheim RCV GmbH & Co KG410
进行中（未招募）
1 期
A study to test whether different doses of BI 456906 are effective in treating adults with type 2 diabetes.type 2 diabetes mellitusMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-002390-60-ITBOEHRINGER-INGELHEIM ITALIA S.P.A.410